Literature DB >> 19138959

Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "Aberrant crypt foci in the adenoma prevention with celecoxib trial".

Richard G Stevens, Theresa P Pretlow, D Paul Hurlstone, Charles Giardina, Daniel W Rosenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19138959     DOI： 10.1158/1940-6207.CAPR-08-0094

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN： 1940-6215


× No keyword cloud information.
  4 in total

1.  HD chromoendoscopy coupled with DNA mass spectrometry profiling identifies somatic mutations in microdissected human proximal aberrant crypt foci.

Authors:  David A Drew; Thomas J Devers; Michael J O'Brien; Nicole A Horelik; Joel Levine; Daniel W Rosenberg
Journal:  Mol Cancer Res       Date:  2014-03-20       Impact factor: 5.852

2.  Proximal Aberrant Crypt Foci Associate with Synchronous Neoplasia and Are Primed for Neoplastic Progression.

Authors:  David A Drew; Allen Mo; James J Grady; Richard G Stevens; Joel B Levine; Bruce M Brenner; Joseph C Anderson; Faripour Forouhar; Michael J O'Brien; Thomas J Devers; Daniel W Rosenberg
Journal:  Mol Cancer Res       Date:  2017-12-08       Impact factor: 5.852

3.  Aberrant crypt foci: the case for inclusion as a biomarker for colon cancer.

Authors:  Michael J Wargovich; Vondina R Brown; Jay Morris
Journal:  Cancers (Basel)       Date:  2010-09-16       Impact factor: 6.639

4.  Characterization of Mucosal Dysbiosis of Early Colonic Neoplasia.

Authors:  Bo-Young Hong; Takayasu Ideta; Bruno S Lemos; Yuichi Igarashi; Yuliana Tan; Michael DiSiena; Allen Mo; John W Birk; Faripour Forouhar; Thomas J Devers; George M Weinstock; Daniel W Rosenberg
Journal:  NPJ Precis Oncol       Date:  2019-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.